4//SEC Filing
Leonard Braden Michael 4
Accession 0001373604-25-000090
CIK 0001880438other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 3:40 PM ET
Size
5.0 KB
Accession
0001373604-25-000090
Insider Transaction Report
Form 4
Leonard Braden Michael
10% Owner
Transactions
- Sale
Common Stock
2025-05-28$1.09/sh−200,000$218,000→ 3,017,432 total(indirect: Holding of BML Investment Partners, L.P.)
Footnotes (1)
- [F1]BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001373603
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 3:40 PM ET
- Size
- 5.0 KB